Radioimmunoscintigraphy of orbital metastases from ovarian carcinoma
Related Experiment Videos
J Bomanji1, J Glaholm, J L Hungerford
1Department of Nuclear Medicine, St. Bartholomew's Hospital, London, United Kingdom.
Clinical Nuclear Medicine
|November 1, 1990
Abstract:
Radioimmunoscintigraphy with I-123 labeled monoclonal antibody HMFG1 has been used for imaging primary and metastatic ovarian neoplasms. Uptake of I-123 labeled HMFG1 is reported in a patient with an orbital metastasis from a primary ovarian adenocarcinoma. Radioimmunoscintigraphy may have a role to play in imaging metastatic orbital neoplasms.